Lupus Nephritis Clinical Trials in Boston, Massachusetts

4 studies are recruiting for lupus nephritis in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

    This is a single-arm, open-label, multicenter, ascending dose Phase 1 study evaluating the safety and preliminary efficacy of CTX112 in adult subjects with refractory autoimmune diseases, including active systemic lupus erythematosus (SLE), systemic sclerosis (SSc), or idiopathic inflammatory myopa…

    Stage
    Phase 1
    Ages
    18 to 70
    Site
    Boston Medical Center, Boston, Massachusetts
    Locations
    16 in total
    Run by
    CRISPR Therapeutics

    See if you can join NCT06925542 on ClinicalTrials.gov

  2. RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

    RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    Tufts Medical Center, Boston, Massachusetts
    Locations
    23 in total
    Run by
    Cabaletta Bio

    See if you can join NCT06121297 on ClinicalTrials.gov

  3. Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

    The overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care treatment.

    Stage
    Phase 2
    Ages
    18 to 100
    Site
    Brigham and Womens Hosp Harvard Med School, Boston, Massachusetts
    Locations
    103 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT05268289 on ClinicalTrials.gov

  4. Lupus Landmark Study: A Prospective Registry and Biorepository

    The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

    Stage
    Not phased
    Ages
    18 to 110
    Site
    Brigham and Women's Hospital, Boston, Massachusetts
    Locations
    25 in total
    Run by
    Lupus Research Alliance

    See if you can join NCT05934149 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.